Evidence map›Paper›PMID 42803656›Full record

ArticleThe Cochrane database of systematic reviews2026

Treat-to-target strategies for low-density lipoprotein cholesterol and triglyceride levels for primary and secondary prevention of cardiovascular disease in adults with dyslipidaemia.

Kamyar Shokraee, Juan Va Franco, Petek Eylul Taneri, Siavosh Olfati, Ana-Mihaela Zorger, Camila Micaela Escobar Liquitay, Nicole Skoetz, Brenda Bongaerts

Abstract read
In one paragraph

Article in The Cochrane database of systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kamyar ShokraeeCochrane Evidence Synthesis Germany/UK, Düsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Juan Va FrancoCochrane Evidence Synthesis Germany/UK, Düsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.ORCID https://orcid.org/0000-0003-0411-899X
Petek Eylul TaneriCochrane Evidence Synthesis Germany/UK, Düsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Siavosh OlfatiCochrane Evidence Synthesis Unit Germany/UK, Institute of Public Health, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Ana-Mihaela ZorgerCochrane Evidence Synthesis Unit Germany/UK, Institute of Public Health, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Camila Micaela Escobar LiquitayCochrane Evidence Synthesis Unit Iberoamérica, Research Department, Universidad del Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Nicole SkoetzCochrane Evidence Synthesis Unit Germany/UK, Institute of Public Health, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Brenda BongaertsCochrane Evidence Synthesis Germany/UK, Düsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis is a protocol for a Cochrane review (intervention). The objectives are as follows: To evaluate the benefits and harms of a treat-to-target (goal-directed) strategy versus a no-target strategy for lipid-lowering therapy in the primary and secondary prevention of cardiovascular disease in adults with dyslipidaemia.

Indexed as

Cardiovascular DiseasesCholesterol, LDLDyslipidemiasHypolipidemic AgentsTriglyceridesHumansPrimary PreventionRandomized Controlled Trials as TopicSecondary PreventionSystematic Reviews as TopicCholesterol, LDLHypolipidemic AgentsTriglycerides

Identifiers

PMID42803656
PMCPMC13618401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.